Aprea Investors
Aprea focuses on the discovery and development of novel anticancer compounds reactivating the tumor suppressor protein p53.
Employee Number:
11-50
Investor Type:
Healthcare Company
Industry:
P4 Medicine
Founded Date:
2003
Headquarters:
Stockholm, Stockholms Lan, Sweden